A detailed history of Sargent Investment Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 47,162 shares of ABBV stock, worth $8.49 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
47,162
Previous 45,692 3.22%
Holding current value
$8.49 Million
Previous $7.84 Million 18.83%
% of portfolio
1.7%
Previous 1.62%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $240,844 - $293,015
1,470 Added 3.22%
47,162 $9.31 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $6.39 Million - $7.46 Million
41,296 Added 939.4%
45,692 $7.84 Million
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $666,928 - $759,903
-4,173 Reduced 48.7%
4,396 $800,000
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $86,000 - $96,856
625 Added 7.87%
8,569 $1.33 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $67,863 - $78,562
-508 Reduced 6.01%
7,944 $1.18 Million
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $60,954 - $75,854
-460 Reduced 5.16%
8,452 $1.14 Million
Q1 2023

May 02, 2023

BUY
$144.61 - $166.54 $70,714 - $81,438
489 Added 5.81%
8,912 $1.42 Million
Q4 2022

Jan 31, 2023

SELL
$138.31 - $165.87 $3,457 - $4,146
-25 Reduced 0.3%
8,423 $1.36 Million
Q3 2022

Oct 26, 2022

BUY
$134.21 - $153.93 $88,578 - $101,593
660 Added 8.47%
8,448 $1.19 Million
Q2 2022

Jul 26, 2022

BUY
$137.62 - $174.96 $53,671 - $68,234
390 Added 5.27%
7,788 $1.19 Million
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $6,598 - $8,187
-50 Reduced 0.67%
7,398 $1.2 Million
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $21,486 - $27,186
200 Added 2.76%
7,448 $1.01 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $18,194 - $20,653
171 Added 2.42%
7,248 $782,000
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $92,058 - $102,558
875 Added 14.11%
7,077 $797,000
Q1 2021

May 04, 2021

BUY
$102.3 - $112.62 $276,210 - $304,074
2,700 Added 77.1%
6,202 $671,000
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $72,441 - $97,803
900 Added 34.59%
3,502 $375,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $20,360 - $23,896
237 Added 10.02%
2,602 $228,000
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $173,520 - $232,195
2,365 New
2,365 $234,000
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $175,747 - $224,646
-2,675 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$77.14 - $90.79 $39,341 - $46,302
-510 Reduced 16.01%
2,675 $216,000
Q4 2018

Feb 12, 2019

BUY
$77.85 - $96.01 $247,952 - $305,791
3,185 New
3,185 $294,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.